Assignee
STORM THERAPEUTICS LTD
GB·3 granted patents·6 pending applications·4 citations·filing 2020–2025
Top patents by PatentIndex Score
9 records- 0192US11725010B2Polyheterocyclic compounds as METTL3 inhibitorsSTORM THERAPEUTICS LTD·Filed 2022·Granted Aug 15, 2023·3 cites·3 claims
- 0278US12358915B2METTL3 inhibitory compoundsSTORM THERAPEUTICS LTD·Filed 2020·Granted Jul 15, 2025·1 cites·18 claims
- 0378US2025122195A1Polyheterocyclic compounds as mettl3 inhibitorsSTORM THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0466US2025388577A1Mettl3 inhibitory compoundsSTORM THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 0564US12195458B2Polyheterocyclic compounds as METTL3 inhibitorsSTORM THERAPEUTICS LTD·Filed 2020·Granted Jan 14, 2025·0 cites·21 claims
- 0656US2024279222A1Processes for the preparation of inhibitory compoundsSTORM THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
- 0753US2023391770A1Mettl3 inhibitory compoundsSTORM THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 0848US2022370453A1Bicyclic heterocyclic compounds as inhibitors of bcdin3d activitySTORM THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 0945US2024277715A1Combination therapies comprising a mettl3 inhibitor and a further anticancer agentSTORM THERAPEUTICS LTD·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →